Evidence map›Paper›PMID 36186434›Full record

ArticleFrontiers in genetics2022

A single-center analysis of genotype-phenotype characteristics of Chinese patients with autosomal dominant polycystic kidney disease by targeted exome sequencing.

Ziyan Yan, Yuchen Wang, Wenfeng Deng, Yi Zhou, Yangcheng Hu, Ka Qi, Ding Liu, Renfei Xia, Rumin Liu, Wenli Zeng and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. How Does ADPKD Severity Differ Between Family Members?Kidney international reports · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ziyan YanDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.
Yuchen WangDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.
Wenfeng DengDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.
Yi ZhouDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.
Yangcheng HuDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.
Ka QiHemodialysis Center, Qinhuangdao Charity Hospital, Qinhuangdao, China.
Ding LiuDivision of Transplantation, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Renfei XiaDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.
Rumin LiuDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.
Wenli ZengDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.
Wei ZhangGuangzhou Jiajian Medical Testing Co Ltd, Guangzhou, China.
Jian XuDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.
Fu XiongDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Yun MiaoDepartment of Transplantation, Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autosomal dominant polycystic kidney diseasemutationPKD1PKD2TES using NGS

Identifiers

PMID36186434
PMCPMC9520363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.